Explore News
-
Weight Loss Drugs Reduce Cancer Risk by 41%
New study reveals significant decrease in cancer risk for obese adults without diabetes using weight…
-
GLP-1 Treatment Breaks New Ground in Addiction Prevention
New research reveals promising findings on GLP-1 drugs and their potential to combat addiction
-
NIH Study Reveals Why 70% of Wegovy Users Hit Plateaus
New NIH research uncovers brain-level resistance to GLP-1 drugs like Ozempic and Wegovy, explaining weight…
-
Why Wegovy May Pose Greater Vision Risks Than Expected
A new analysis of FDA adverse event data links Wegovy to a significantly higher risk…
-
70% of Patients Achieve Weight Loss with Semaglutide Post-Surgery
New research reveals that semaglutide, a GLP-1 receptor agonist, significantly aids weight loss in patients…
-
Ozempic Weight Loss Tied to Major Health Benefits, Study Reveals
New research shows that patients who lost the most weight on GLP-1 drugs like Ozempic…
-
Semaglutide Cuts Migraine Relief Drug Use by 30% in Women
A new study finds that women taking semaglutide for weight loss or diabetes experienced fewer…
-
Endoscopic Procedure Surges Ahead in Weight Loss Trial
A new study finds endoscopic sleeve gastroplasty leads to significantly greater weight reduction than oral…
-
Semaglutide Boosts Motivation in 78% of MDD Patients
A new JAMA Psychiatry study finds semaglutide significantly enhances motivation in patients with major depressive…
-
70% of Patients Lose 15% Body Weight on New Drugs
Drugs like Wegovy and Mounjaro mimic gut hormones to regulate hunger and insulin, offering unprecedented…
